# Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis

> **NCT00468208** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 20 (actual)

## Conditions studied

- Wegener's Granulomatosis

## Interventions

- **DRUG:** Abatacept

## Key facts

- **NCT ID:** NCT00468208
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-01-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00468208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00468208, "Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00468208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*